Fibrillary tau aggregates are hallmark neuropathologies in diverse neurodegenerative disorders, including Alzheimer’s disease (AD), progressive supranuclear palsy, corticobasal degeneration, and Pick’s disease, collectively referred to as tauopathies. This evidence concerns the gene MAPT and tauopathy.